selenium has been researched along with Peritoneal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, K; Tan, Y; Wang, X; Wu, S; Zhang, J | 1 |
| Behne, D; Bornkamm, GW; Dong, HF; Eckhaus, M; Felix, K; Gerstmeier, S; Howard, OM; Janz, S; Kyriakopoulos, A | 1 |
2 other study(ies) available for selenium and Peritoneal Neoplasms
| Article | Year |
|---|---|
Efficacy and safety of selenium nanoparticles administered intraperitoneally for the prevention of growth of cancer cells in the peritoneal cavity.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Proliferation; Male; Mice; Nanoparticles; Neoplasm Seeding; Peritoneal Neoplasms; Selenium | 2014 |
Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice.
Topics: Animals; Chemotaxis; Diet; Inflammation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Oxidation-Reduction; Peritoneal Neoplasms; Plasmacytoma; Selenium; Terpenes; Tissue Distribution | 2004 |